Effects of amiodarone, sematilide, and sotalol on QT dispersion
Authors:
- Luyi SenLSLuyi Sen
- Philip SagerPSPhilip Sager
- Parveen UppalPUParveen Uppal
- Bramah N. SinghBSBramah N. Singh
- 1 November 1994
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 74 (9) , 896-900
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.Circulation, 1993
- Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)The American Journal of Cardiology, 1993
- Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agentsThe American Journal of Cardiology, 1993
- Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.Circulation, 1992
- Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot studyJACC, 1992
- Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.Circulation Research, 1991
- QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.Heart, 1990
- Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillationJACC, 1989
- The historical development, cellular electrophysiology and pharmacology of amiodaroneProgress in Cardiovascular Diseases, 1989
- Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac TissueCirculation Research, 1970